Search research articles
Contact Us
Filters
Showing results (721-730 of 1,398) with videos related to
Page
of 140
Sort By:
JIMD Reports
|
April 22, 2026
Should PNPO Deficiency Be Treated In Utero? Clinical Findings From Prenatal Pyridoxine Therapy
Chloé de Puyraimond, Samia Pichard, Muriel Girard, et al.
Nature Communications
|
March 6, 2025
DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis
Wei Liu, Jun Li, Yitao Tang, et al.
Oncogene
|
December 17, 1997
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
H J Xu, Y Zhou, W Ji, et al.
Seminars in Oncology
|
November 14, 2001
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy
G B Mills, Y Lu, X Fang, et al.
British Journal of Cancer
|
September 25, 2008
A novel AKT3 mutation in melanoma tumours and cell lines
M A Davies, K Stemke-Hale, C Tellez, et al.
Discovery Medicine
|
February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps
Ann M Bailey, Yong Mao, Jia Zeng, et al.
International Journal of Oncology
|
July 6, 2007
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway
Veronica C Estrella, Astrid M Eder, Shuying Liu, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
Dimpy Koul, Ruijun Shen, Sherry Bergh, et al.
The Journal of Clinical Investigation
|
June 16, 2015
Death-associated protein kinase 1 promotes growth of p53-mutant cancers
Jing Zhao, Dekuang Zhao, Graham M Poage, et al.
Annals of Neurology
|
August 28, 2007
An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1)
Gajja S Salomons, Levinus A Bok, Eduard A Struys, et al.
Page
of 140
Search research articles
Search
Showing results (721-730 of 1,398) with videos related to
Sort By:
Page
of 140
JIMD Reports
|
April 22, 2026
Should PNPO Deficiency Be Treated In Utero? Clinical Findings From Prenatal Pyridoxine Therapy
Chloé de Puyraimond, Samia Pichard, Muriel Girard, et al.
Nature Communications
|
March 6, 2025
DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis
Wei Liu, Jun Li, Yitao Tang, et al.
Oncogene
|
December 17, 1997
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
H J Xu, Y Zhou, W Ji, et al.
Seminars in Oncology
|
November 14, 2001
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy
G B Mills, Y Lu, X Fang, et al.
British Journal of Cancer
|
September 25, 2008
A novel AKT3 mutation in melanoma tumours and cell lines
M A Davies, K Stemke-Hale, C Tellez, et al.
Discovery Medicine
|
February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps
Ann M Bailey, Yong Mao, Jia Zeng, et al.
International Journal of Oncology
|
July 6, 2007
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway
Veronica C Estrella, Astrid M Eder, Shuying Liu, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
Dimpy Koul, Ruijun Shen, Sherry Bergh, et al.
The Journal of Clinical Investigation
|
June 16, 2015
Death-associated protein kinase 1 promotes growth of p53-mutant cancers
Jing Zhao, Dekuang Zhao, Graham M Poage, et al.
Annals of Neurology
|
August 28, 2007
An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1)
Gajja S Salomons, Levinus A Bok, Eduard A Struys, et al.
Page
of 140